The plasma membrane (PM), a dynamic phospholipid bilayer, functions as an essential biophysical barrier demarcating the intracellular microenvironment from the extracellular milieu. This phospholipid bilayer not only maintains ionic homeostasis via selective permeability mechanisms but also coordinates critical cellular functions such as transmembrane signal transduction, vesicular trafficking, and intercellular communication. Pathological alterations in plasma membrane integrity, which may arise from structural destabilization (
e.g., lipid peroxidation) or functional dysregulation (
e.g., ion channel malfunction), can trigger progressive depolarization cascades. This ultimately leads to cytoplasmic contents efflux and necroptotic cell death.
[1] Accordingly, understanding the spatiotemporal organization and biophysical properties of cell membranes is of paramount importance for advancing research in precision medicine and molecular diagnostics.
[2] Leveraging their noninvasiveness, specificity, and real-time detection capability, fluorescence imaging with PM-targeted probes has emerged as a powerful technique for dynamic tracking and therapeutic monitoring.
[3-4] While substantial breakthroughs have been achieved in the design of membrane- specific fluorescent probes, clinical translation remains hindered by challenges in the biocompatibility and photophysical properties of probes. For instance, the established cyanine dyes (DiD, DiI, DiO and DiR), despite their widespread utilization in membrane imaging, display critical performance limitations encompassing aqueous insolubility, inadequate membrane retention efficacy, photostability deficits, and aggregation-caused fluorescence quenching.
[5-6] These intrinsic technical limitations have spurred the evolution of rationally designed fluorescent probes with enhanced PM imaging performance.
[7-9]